Skip to main content
. 2024 May 30;22:520. doi: 10.1186/s12967-024-05347-9

Fig. 11.

Fig. 11

Biomimetic nanoparticles encapsulating DTX for lung cancer treatment. A Schematic representation of in vivo delivery using PM/PLGA/DTX nanoparticles. B Graph showing the release of DTX in vitro in PBS (pH 7.4) at 37 °C for PLGA/DTX, PM/PLGA/DTX, and free DTX, with averages shown as mean ± SD (n = 3). C The volume of tumors in mice and D the rates of tumor suppression following administration of free DTX, PLGA/DTX, and PM/PLGA/DTX, reported as mean ± SD (n = 8), ***P < 0.001. E Examination of tissue pathology; H&E-stained tumor tissue images from treatments with free DTX, PLGA/DTX, and PM/PLGA/DTX. Scale bar = 50 μm. F Quantitative assessment of the necrotic areas within tumors for each treatment group

(Reprinted with permission from [105])